Lactulose: pharmacodynamic evaluation
Baglioni, A.; Dubini, F.
Bollettino Chimico Farmaceutico 115(10): 720-725
1976
ISSN/ISBN: 0006-6648 PMID: 1016601 Document Number: 104457
Document emailed within 1 workday
Related Documents
Schumann, C. 1992: The lactulose challenge. Part 1. on the cholesterol lowering effect of lactulose Zeitschrift für Arztliche Fortbildung 86(18): 901-904Hasan, S.; Datta, S.; Bhattacherjee, S.; Banik, S.; Saha, S.; Bandyopadhyay, D. 2018: A Randomized Controlled Trial Comparing the Efficacy of a Combination of Rifaximin and Lactulose with Lactulose only in the Treatment of Overt Hepatic Encephalopathy Journal of the Association of Physicians of India 66(1): 32-36
Bovo, P.; Paola Brunori, M.; di Francesco, V.; Frulloni, L.; Montesi, G.; Cavallini, G. 1992: The menstrual cycle has no effect on gastrointestinal transit time. Evaluation by means of the lactulose H2 breath test Italian Journal of Gastroenterology 24(8): 449-451
Vendemiale, G.; Palasciano, G.; Cirelli, F.; Altamura, M.; De Vincentiis, A.; Altomare, E. 1992: Crystalline lactulose in the therapy of hepatic cirrhosis. Evaluation of clinical and immunological parameters. Preliminary results Arzneimittel-Forschung 42(7): 969-972
Loomer, H.P.; Saunders, J.C.; Kline, N.S. 1957: A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer Psychiatric Research Reports 8: 129-141
Fotherby, K.; Saxena, B.N.; Shrimanker, K.; Hingorani, V.; Takker, D.; Diczfalusy, E.; Landgren, B.M. 1980: A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate Fertility and Sterility 34(2): 131-139
Westhoff, C.L.; Chen, B.A.; Jensen, J.T.; Barnhart, K.; Thomas, M.; Teal, S.; Blithe, D. 2018: Phase I/Ii pharmacokinetic and pharmacodynamic evaluation of two levonorgestrel-only contraceptive patches in a multicenter randomized trial Contraception 2018
Mercier, R.C.; Houlihan, H.H.; Rybak, M.J. 1997: Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium Antimicrobial Agents and ChemoTherapy 41(6): 1307-1312
Sastri, M.S.; Satyanarayana, N.V.; Krishna, D.R.; Diwan, P.V. 1993: In vitro and in vivo studies on slow release propranolol hydrochloride suppositories. Pharmacokinetic and pharmacodynamic evaluation Arzneimittel-Forschung 43(3): 320-323
Cawello, W.; Rosenkranz, B.; Schmid, B.; Wierich, W. 2013: Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers Epilepsia 54(3): 530-536
Ray, J.; Chawla, Y.K. 1996: Lactulose in clinical use Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 17(2): 12-14
Kersh, E.S.; Rifkin, H. 1973: Lactulose enemas Annals of Internal Medicine 78(1): 81-84
1980: Lactulose (Chronulac) for constipation Medical Letter on Drugs and Therapeutics 22(1): 2-4
1976: Lactulose for hepatic encephalopathy Medical Letter on Drugs and Therapeutics 18(1): 3-4
Van der Vliet, H.J.; van Bodegraven, A.A. 2004: Megacolon during treatment with lactulose Nederlands Tijdschrift Voor Geneeskunde 148(20): 998-1001
Baskaran, V.; Murthy, K.N.; Mahadevamma; Vishwanatha, S.; Lokesh, B.R. 2001: Sub chronic toxicity studies of lactulose in rats Indian Journal of Experimental Biology 39(5): 441-446
Huang, P.; Gou, W.L.; Wang, X.T.; Ding, Y.L.; He, J.; Wang, C.H. 2016: Lactulose oral solution for the treatment of postpartum constipation Journal of Biological Regulators and Homeostatic Agents 30(2): 523-528
Fung, W.P.; Khoo, O.T. 1971: Lactulose in the treatment of acute and chronic hepatic encephalopathy Singapore Medical Journal 12(3): 176-180
Patial, R.K. 2001: Lactulose in the prevention of recurrent urinary tract infection Journal of the Association of Physicians of India 49: 1214
Ratnaike, R.N.; O'Halloran, M.W.; Hislop, I.G. 1972: Lactulose lowers arterial ammonia in hepatic failure American Journal of Gastroenterology 58(6): 626-632